Company intelligence / Profile preview

Monarch LifeSciences

Indianapolis, Indiana, USA

Ownership: Private
Development stage: Other

Overview

Monarch LifeSciences was a specialized contract research organization (CRO) that provided proteomics-based biomarker discovery and validation services to the pharmaceutical and biotechnology industries. Headquartered in Indianapolis, the company utilized advanced mass spectrometry platforms to offer protein quantification, characterization, and expression profiling. Their services were designed to accelerate drug development by identifying and monitoring biomarkers across various stages of research. In 2012, Monarch LifeSciences was acquired by Eurofins Scientific, integrating its expertise into Eurofins' global bioanalytical service network.

Industry: Drug Discovery Services

Beyond the preview

Go deeper on Monarch LifeSciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Monarch LifeSciences.

Explore the full profile